Cook social media site to educate on ED

Share this article:
In an effort to educate physicians and consumers about a complex and painful form of erectile dysfunction know as Peyronie's disease, device manufacturer Cook Medical recently launched an unbranded physician education focused website found online at

The social networking microsite was designed to provide the most current information on Peyronie's, offering professionals and their patients public forums for discussing the disease.

“We are starting to think about how the future readers of medical news will gather their information,” said SVP and global strategic business unit leader for Cook Urology, Jerry French. “When I talk to urologists now, these people are getting their information online. One of the hallmarks for Cook has always been education, especially on the physician side,” French said. “Peyronie's is an issue that not a lot of people know about. We figured this would be a good opportunity for us to test the water on social media.”

Cook Medical is the maker of Surgisis Biodesign, a technology used for the replacement and repair of damaged human tissue in surgery. Surgisis Biodesign is used in various procedures, including Peyronie's repair. Surgisis Biodesign is derived from the small intestine of pigs and communicates with the body by signaling surrounding tissue to grow.
Share this article:

Next Article in News

Email Newsletters

More in News

Lack of marketing partner delays Afrezza launch

Lack of marketing partner delays Afrezza launch

Afrezza was heralded as one of the most innovative diabetes products of the last decade. So, why hasn't MannKind set a firm launch date for the product?

In sunny world of LASIK marketers, a dark underbelly

In sunny world of LASIK marketers, a dark ...

Last week, the former FDA branch chief who originally approved LASIK machines asked FDA to reconsider its denial last month of his petition to ban these devices.

BMS Q2 sales slip, Eliquis, Yervoy soar

BMS Q2 sales slip, Eliquis, Yervoy soar

The company attributed part of the Eliquis boost to the BMS-Pfizer DTC and education efforts.